Project Grant HT94252510202
Award Date
4/15/25
Completion Date
4/14/28
Dollars Obligated
$1.6M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Lexington, KY 40526, USA
Similar Awards
The University of Kentucky Research Foundation received a $1,377,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award, running from June 1, 2024 to May 31, 2027, supports research on PLK1 in prostate cancer lineage plasticity. As a non-profit subsidiary of the University of Kentucky, the Research Foundation facilitates the university's participation in federal grants and contracts by managing intellectual property...
The University of Kentucky Research Foundation has received a $2,061,903 Project Grant award from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct a 4-year research project titled "Novel Calcitropes as Targets for Cardiomyopathy Treatment". This award aims to support innovative biomedical research focused on developing new treatments for heart disease. The Research Foundation, a non-profit subsidiary of the University of...
The University of Kentucky Research Foundation has been awarded a $612,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) from the Defense Health Agency. The grant will fund the development of a new personalized medicine model for high-risk pediatric sarcomas, with a performance period from August 1, 2024 to July 31, 2026. As the prime awardee, the Research Foundation will leverage its expertise in biomedical research and collaborative partnerships to...
The University of Kentucky Research Foundation was awarded a $2,988,630 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program. The grant will fund the development of visual-motor coordination assessments and decision support tools to optimize return to duty for patients with chronic ankle instability from September 1, 2022 to August 31, 2026. The Military Medical Research and Development program supports basic,...
The Department of the Army Medical Command awarded Duke University a $472,184 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 1, 2022 to August 31, 2024 to exploit ferropotosis for the treatment of RB1-deficient lethal prostate cancer. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care...
The University of Kentucky Research Foundation was awarded a $1,376,999 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420) on September 15, 2022. The grant will fund the development of a highly selective MPGES-1 inhibitor as a non-opioid treatment for chronic pain through September 14, 2026. The Military Medical Research and Development program supports basic, applied, and advanced biomedical...
The Department of the Army Medical Command awarded a $699,534 project grant to the Institute of Cancer Research: Royal Cancer Hospital under the Military Medical Research and Development program (CFDA 12.420). The three-year grant will support research on B7-H3 (CD276) as a therapeutic target in lethal prostate cancers. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research that investigates medical solutions...
The U.S. Defense Health Agency awarded a $1,449,000 Project Grant to Duke University to conduct research aimed at "Identifying Essential Molecular Mechanisms for Advanced Prostate Cancer Growth by a New Chemical Compound." This grant is funded under the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to improve the health and care of military service members, veterans, and their families. The...
The Department of the Army Medical Command awarded Duke University a $2,139,404 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to support research on exploiting a new targetable node in the androgen receptor (AR) signaling pathway in prostate cancer. The three-year award runs from January 7, 2022 to June 30, 2025. Duke University will conduct research to transform healthcare for service members and the public through innovative and impactful medical...
This Department of Defense Project Grant award in the amount of $1,215,057, effective September 1, 2023, supports a 3-year research project titled "TARGETING NNMT TO INHIBIT OBESITY-ASSOCIATED BREAST CANCER DEVELOPMENT AND PROGRESSION". The award was made to the University of Kentucky Research Foundation under the Military Medical Research and Development (CFDA 12.420) federal grant program. This program funds a range of biomedical research to transform healthcare for Service...